Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Genentech
 More »

  • Novartis Inks Agreement for ImmunoGen's "TAP" ADC Technology
    emtansine) for patients with HER2-positive, metastatic breast cancer, approved by the FDA in February and marketed in the United States by Roche subsidiary Genentech. ...
    10-11-2013
  • Ovarian Cancer Treatment Options Multiply
    ... Avastin® by Roche/Genentech/Chugai and trebananib by Amgen were cited as leading contenders. Amgen's trebananib is in Phase III trials. This investigational peptibody-a hybrid ...
    10-8-2013
  • FDA Speeds Things Up
    Bristol-Myers Squibb, Genentech, Amplimmune, and CureTech all similarly have drugs directed at either PD-1 or its ligand. But, according to Dr. Hamid, the lambrolizumab antibody is ...
    10-1-2013
  • Takeover Targets: Who Is First on the List?
    ... crafting of ADC licensing agreements with 12 biopharmas-including giants like AbbVie, Bayer, Genentech, GSK, and Pfizer-which have generated more than $225 million for the company. ...
    9-24-2013
  • Google Eyes Wider Healthcare Footprint with Tech-Focused Calico
    Calico, as the new company is called, will be run separately from Google. Heading Calico will be Arthur Levinson, the chairman of Roche's Genentech subsidiary and former CEO ...
    9-19-2013
  • Cell-Based Assays: Getting Back to Basics
    ... Roquemore. "Most recently, in a collaboration with Genentech to identify and assess the cardiotoxic potential of selective kinase inhibitors, we identified all compounds in the set ...
    9-15-2013
  • FDA Panel Urges Fast Approval of Perjeta for Early-Stage Breast...
    Genentech, a subsidiary of Roche, won FDA approval in June 2012 for Perjeta, but for use ... ODAC said its recommendation was based on results submitted by Roche Genentech from two ...
    9-13-2013
  • Roche Signs Up to $422.5M Collaboration with Inovio
    Based on promising earlier studies, Roche and Genentech are recruiting patients for five studies studies investigating MPDL3280A, accordnig to clinicaltrials.gov posts last updated ...
    9-10-2013
  • Lasker Awards Announced: Genentech VP Honored
    Drs. Scheller (Genentech) and Südhof (Stanford University School of Medicine) will ... Scheller, 59, executive vice president, research and early development at Genentech, and ...
    9-9-2013
  • As Big Deals Resurface, Who's Next to the Altar?
    ... He cited the company's antibody-drug conjugate licensing agreements with 12 biopharmas-including giants such as AbbVie, Bayer, Genentech, GlaxoSmithKline, and Pfizer-that have ...
    9-9-2013
  • FDA Speeds Things Up
    Bristol-Myers Squibb, Genentech, Amplimmune, and CureTech all similarly have drugs directed at either PD-1 or its ligand. But, according to Hamid, the lambrolizumab antibody is the ...
    9-3-2013
  • Spreading Sunshine on What Biopharma Pays Physicians
    health care professionals," Mastrojohn said-comments echoed by Genentech and Novartis. ... Roche's Genentech subsidiary will let providers review payment data before submission to ...
    8-29-2013
  • Sangamo Expands AAV Capabilities with Ceregene Acquisition
    In March, Ceregene obtained from Roche's Genentech subsidiary a license for exclusive worldwide rights to NGF and another gene, neurotrophic factor 4/5 (NT-4/5); financial terms ...
    8-27-2013
  • Novartis, Ensemble Therapeutics Launch Collaborations
    Those partners include Alexion Pharmaceuticals, Boehringer Ingelheim, Bristol-Myers Squibb, Genentech, and Pfizer. One collaboration focuses on IL-17 antagonists; the other uses ...
    8-6-2013
  • Companion Diagnostics: Improving Development Success and Patient...
    Growing interest in theranostics boosts promise of personalized medicine. Interest in the development of companion diagnostics has recently surged; regulatory agencies such as the ...
    8-5-2013

  • Journal Articles

  • Neoadjuvant Immunotherapy Enhances Radiosensitivity Through Natural...
    Chau-Hwa Chi, Yu-Shan Wang, Chieh-Han Yang, Kwan-Hwa Chi
    Cancer Biotherapy and Radiopharmaceuticals
    The radiosensitization effect of combined CpG and Herceptin® (Genentech, Inc., South San Francisco, CA) (CpG/Herceptin), given before or after radiation, was evaluated by using a ...
  • Effect of Antilymphoma Antibody, 131 I-Lym-1, on Peripheral Blood...
    Orazio Schillaci, Gerald L. DeNardo, Sally J. DeNardo, Desiree S. Goldstein, Linda A. Kroger, Robert T. O'Donnell, Kathleen R. Lamborn
    Cancer Biotherapy and Radiopharmaceuticals
    ABSTRACT Anti-CD20 monoclonal antibodies (mAbs), unlabeled rituximab (Rituxan®, Biogen Idec Inc., Cambridge, MA; and Genentech Inc., South San Francisco, CA) or radiolabeled ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Balancing Family and Career for Women Ph.D.s

Which changes made to academic culture are most likely to encourage women researchers to stay?

Suggest a Poll